Back
Aprea Therapeutics, Inc. 10K Form
Sell
26
APRE
Aprea Therapeutics, Inc.
Last Price:
$0.91
Seasonality Move:
-7.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APRE News And Ratings
See the #1 stock for the next 7 days that we like better than APRE
APRE Financial Statistics
Sales & Book Value
| Annual Sales: | $1.5M |
|---|---|
| Cash Flow: | $-3.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.83 |
| Price / Book: | 0.53 |
Profitability
| EPS (TTM): | -2.14100 |
|---|---|
| Net Income (TTM): | $-13M |
| Gross Margin: | $1.5M |
| Return on Equity: | -75.35% |
| Return on Assets: | -63.46% |
Aprea Therapeutics, Inc. Earnings Forecast
Key Aprea Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 8 years for APRE is 98.52%.
-
The Selling, General & Administrative Expenses for APRE have been equal to 429.83% of Gross Profit Margin.
-
The Research & Development expenses have been 623.15% of Revenue.
-
The Net Earning history of APRE is -862.42% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 4 years.
Aprea Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APRE |
| CUSIP: | 03836J |
| Website: | aprea.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.2 |
| Quick Ratio: | 5.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APRE Technical Analysis vs Fundamental Analysis
Sell
26
Aprea Therapeutics, Inc. (APRE)
is a Sell
Is Aprea Therapeutics, Inc. a Buy or a Sell?
-
Aprea Therapeutics, Inc. stock is rated a SellThe current Aprea Therapeutics, Inc. [APRE] share price is $0.91. The Score for APRE is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.